Post job

TransMedics's revenue is $441.5 million.

What is TransMedics's revenue?

TransMedics's annual revenue is $441.5M. Zippia's data science team found the following key financial metrics about TransMedics after extensive research and analysis.
  • TransMedics's revenue growth from 2018 to 2024 is 3,292.03%.
  • TransMedics has 110 employees, and the revenue per employee ratio is $4,014,000.
  • TransMedics's peak quarterly revenue was $121.6M in 2024(q4).
  • TransMedics peak revenue was $441.5M in 2024.
  • TransMedics annual revenue for 2023 was 241.6M, 158.53% growth from 2022.
  • TransMedics annual revenue for 2024 was 441.5M, 82.74% growth from 2023.

On this page

Most recent quarter revenue
$121.6M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$441.5M (2024)
Company peak revenue
Revenue / employee
$4.0M
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$121.6M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$441.5M (2024)
Company peak revenue
Revenue / employee
$4.0M
Company revenue / employee

TransMedics historical revenue

TransMedics's peak revenue was $441.5M in 2024. The peak quarterly revenue was $121.6M in 2024(q4).

TransMedics's revenue increased from $13.0m in 2018 to $441.5M currently. That's a 3,292.03% change in annual revenue.

TransMedics annual revenue

$442M
$353M
$265M
$177M
$88M
$0
2019
2020
2021
2022
2023
2024

TransMedics annual revenue over time

Fiscal year / yearTransMedics revenue
2018$13.0M
2019$23.6M
2020$25.6M
2021$30.3M
2022$93.5M
2023$241.6M
2024$441.5M

How accurately did TransMedics' revenue projections match actual performance?

Zippia waving zebra

TransMedics annual growth

TransMedics saw the greatest revenue growth in 2022, when revenue increased by 208.83%.

TransMedics had the lowest revenue growth in 2020, when revenue changed by 8.62%.

TransMedics annual growth rate over time

YearTransMedics growth
2019
81%
2020
9%
2021
18%
2022
209%
2023
159%
2024
83%

TransMedics quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$122M
$97M
$73M
$49M
$24M
$0
2020
2021
2022
2023
2024

TransMedics quarterly growth rate over time

YearQ1Q2Q3Q4
2018---$3.5M
2019$4.7M$5.7M$7.2M$6.1M
2020$7.5M$3.4M$7.1M$7.6M
2021$7.1M$8.2M$5.4M$9.7M
2022$15.9M$20.5M$25.7M$31.4M
2023$41.6M$52.5M$66.4M$81.2M
2024$96.9M$114.3M$108.8M$121.6M

TransMedics jobs nearby

Do you work at TransMedics?

Is TransMedics transparent about its revenue structure?

TransMedics financial information

IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number110
Date Founded1998
HeadquartersAndover, Massachusetts
Revenue$441.5M
Net Income-$36,231,000
Gross Proft$262.1M (2024)
Tax Rate0.0%
Total Assets$277,147,000
TickerTMDX

TransMedics jobs you might like

TransMedics financing

TransMedics received early financing of $8.0M on 2000-09-21.

SeriesRound sizeDate
Series A$8M09/2000
Series B$27.6M01/2004
Series C$29.8M03/2006
Series D$25.5M04/2007
Debt Financing$2.5M07/2009
Debt Financing$3.6M11/2009
Series E$36M03/2010
Series Unknown$6M08/2011
Series Unknown$36M11/2012
Series Unknown$20M06/2015
Series Unknown$500K09/2015
Series F$51.2M05/2016
Private Equity$12.5M07/2016
Post Ipo Debt$2.2M04/2020

TransMedics investors

InvestorsSecurity type
Sofinov Societe Financiere D'InnovationSeries A
MEDEQUITY CAPITAL LLCSeries A
Alta PartnersSeries A
WASHINGTON MUTUAL BANKSeries A
Novel Bioventures LLCSeries B
Sherbrooke CapitalSeries B
CDP Capital Technology VenturesSeries B
CB Health Ventures LLCSeries B
3i PLCSeries B
Alta PartnersSeries B
POSCO BioVentures IncSeries B
Flagship Pioneering IncSeries B
Vantage Point Capital PartnersSeries C
Sherbrooke CapitalSeries C
CB Health Ventures LLCSeries C
Sagamore BioventuresSeries C
3i PLCSeries C
Alta PartnersSeries C
POSCO BioVentures IncSeries C
Flagship Pioneering IncSeries C
Vantage Point Capital PartnersSeries D
Sherbrooke CapitalSeries D
CB Health Ventures LLCSeries D
Sagamore BioventuresSeries D
Tudor InvestmentsSeries D
3i PLCSeries D
Alta PartnersSeries D
POSCO BioVentures IncSeries D
Flagship Pioneering IncSeries D
Vantage Point Capital PartnersSeries E
Foundation Capital LLCSeries E
Sherbrooke CapitalSeries E
Excel Venture ManagementSeries E
CB Health Ventures LLCSeries E
Sagamore BioventuresSeries E
3i PLCSeries E
Tudor InvestmentsSeries E
Alta PartnersSeries E
Kleiner PerkinsSeries E
POSCO BioVentures IncSeries E
Flagship Pioneering IncSeries E
Abrams CapitalSeries Unknown
Kleiner PerkinsSeries Unknown
Flagship Pioneering IncSeries Unknown
HERCULES CAPITAL INCSeries Unknown
Lung Biotechnology PBCSeries F
Abrams CapitalSeries F
BioStar CapitalSeries F
Inbio VenturesSeries F
Millhouse CapitalSeries F
Kleiner PerkinsSeries F
Flagship Pioneering IncSeries F
Fayerweather FundSeries F
Lung Biotechnology PBCPrivate Equity
Abrams CapitalPrivate Equity
PharmstandardPrivate Equity
BioStar CapitalPrivate Equity
Inbio VenturesPrivate Equity
Kleiner PerkinsPrivate Equity
Flagship Pioneering IncPrivate Equity
Fayerweather FundPrivate Equity

TransMedics competitors

TransMedics's top competitor, Emergent BioSolutions, earned an annual revenue of $1.6B.

TransMedics's smallest competitor is Abiomed with revenue of $1.0B last year.

TransMedics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of TransMedics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TransMedics. The employee data is based on information from people who have self-reported their past or current employments at TransMedics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TransMedics. The data presented on this page does not represent the view of TransMedics and its employees or that of Zippia.

TransMedics may also be known as or be related to TransMedics, TransMedics Inc, TransMedics, Inc., Transmedics and Transmedics, Inc.